RHUBESTRYN™ is a specialized formula designed to address the diverse facets of menopause. It features rhapontic rhubarb root extract (ERR), a clinically researched ingredient renowned for its therapeutic benefits and comprehensive relief.
DISCLAIMER
Consult your healthcare professional before use if pregnant, nursing, taking medications, or for any use by minors. Do not use if safety seal is broken or missing. KEEP OUT OF REACH OF CHILDREN. The products on this site have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed health care professional before beginning, changing or stopping any supplementation regimen.
RHUBESTRYN™
Menopause is a natural and transformative phase in a woman’s life, typically occurring in the late 40s or early 50s. Hormonal shifts, marked by a decline in estrogen and progesterone, lead to various common symptoms such as hot flashes, night sweats, mood swings, physical and mental fatigue, sexual frustration, and sleep disturbances. The onset of these symptoms commonly begins several years before menopause and persists for up to 5 years after, significantly affecting daily life and overall wellbeing. By harnessing the researched benefits of rhapontic rhubarb root extract (ERR), RHUBESTRYN™ specifically addresses hormone balance, maintains a normal inflammatory balance, and provides antioxidant support to help women navigate the challenges of menopause with greater ease and wellbeing.
Suggested Use: 1 capsule per day or as recommended by your health care professional.
Rhapontic Rhubarb Root Extract (ERR)
ERR is a phytoestrogen extract derived from the roots of rhapontic rhubarb (Rheum rhaponticum L.) and is recognized in scientific literature as a solution for menopausal complaints. Specifically, ERR functions as a selective estrogen receptor modulator (SERM), meaning it selectively targets estrogen receptor β (ERβ) in the body without affecting estrogen receptor α (ERα). This crucial specificity, documented in in-vitro studies, allows ERR to deliver its benefits and address menopausal symptoms without influencing other estrogen receptors in the body.